These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8871596)

  • 21. Characterization of CD25-positive T cells during syngeneic pregnancy: production of stimulatory class II MHC molecules.
    Kyvelidou C; Chatzi K; Semitekolou M; Papathanassiou X; Vassiliadis S; Athanassakis I
    Scand J Immunol; 2009 Dec; 70(6):584-95. PubMed ID: 19906201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Requirement for efficient interactions between CD4 and MHC class II molecules for survival of resting CD4+ T lymphocytes in vivo and for activation-induced cell death.
    Maroto R; Shen X; König R
    J Immunol; 1999 May; 162(10):5973-80. PubMed ID: 10229835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A functional role for signal transduction via the cytoplasmic domains of MHC class II proteins.
    St-Pierre Y; Nabavi N; Ghogawala Z; Glimcher LH; Watts TH
    J Immunol; 1989 Aug; 143(3):808-12. PubMed ID: 2473111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cells and resting B cells form clusters in vitro and in vivo: T cell independence, partial LFA-1 dependence, and regulation by cross-linking surface molecules.
    Kushnir N; Liu L; MacPherson GG
    J Immunol; 1998 Feb; 160(4):1774-81. PubMed ID: 9469436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes.
    Loyer V; Fontaine P; Pion S; Hétu F; Roy DC; Perreault C
    J Immunol; 1999 Dec; 163(12):6462-7. PubMed ID: 10586037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extensive and bidirectional transfer of major histocompatibility complex class II molecules between donor and recipient cells in vivo following solid organ transplantation.
    Brown K; Sacks SH; Wong W
    FASEB J; 2008 Nov; 22(11):3776-84. PubMed ID: 18632850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
    Frey AB; Cestari S
    Cell Immunol; 1997 May; 178(1):79-90. PubMed ID: 9184701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen.
    Diaz LA; Pai R; Endres J; Anthony P; Duzyj C; Bishu S; Morita Y; Fox DA
    J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation.
    Mannie MD; Nardella JP; White GA; Arnold PY; Davidian DK
    Cell Immunol; 1998 Jun; 186(2):111-20. PubMed ID: 9665753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of Ia molecules in the activation of T lymphocytes. II. Ia-restricted recognition of allo K/D antigens is required for class I MHC-stimulated mixed lymphocyte responses.
    Rock KL; Barnes MC; Germain RN; Benacerraf B
    J Immunol; 1983 Jan; 130(1):457-62. PubMed ID: 6600193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective elimination of antigen-specific line T cells and ex vivo antigen-primed lymph node cells by antigen-targeted drug-labeled antigen-presenting cell membranes.
    Chang NH; Boggs JM
    Cell Immunol; 1997 Mar; 176(2):135-45. PubMed ID: 9073386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presentation of peptides and proteins by intestinal epithelial cells.
    Hoyne GF; Callow MG; Kuo MC; Thomas WR
    Immunology; 1993 Oct; 80(2):204-8. PubMed ID: 8262549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of functional I-Ed variants from an antigen-presenting macrophage cell line.
    Schwarzbaum S; Diamond B
    J Immunol; 1985 Jul; 135(1):141-6. PubMed ID: 3873487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haplotype-specific suppression of experimental allergic encephalomyelitis with anti-IA antibodies.
    Sriram S; Topham DJ; Carroll L
    J Immunol; 1987 Sep; 139(5):1485-9. PubMed ID: 3497972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presentation of myelin basic protein by murine cerebral vascular endothelial cells.
    McCarron RM; Kempski O; Spatz M; McFarlin DE
    J Immunol; 1985 May; 134(5):3100-3. PubMed ID: 2580013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-I-A antibody modulation of lymphocyte traffic in hapten-stimulated inbred mice.
    Carroll AM; Greene MI
    Immunology; 1987 Nov; 62(3):471-5. PubMed ID: 3499382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.
    Ozato K; Sachs DH
    J Immunol; 1981 Jan; 126(1):317-21. PubMed ID: 6935293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen presentation by murine epidermal langerhans cells and its alteration by ultraviolet B light.
    Stingl G; Gazze-Stingl LA; Aberer W; Wolff K
    J Immunol; 1981 Oct; 127(4):1707-13. PubMed ID: 6168700
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.